Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders.

Privitera D, Corti V, Alessio M, Volontè MA, Lampasona V, Comi G, Martino G, Franciotta D, Furlan R, Fazio R.

Neurol Sci. 2013 Mar;34(3):313-20. doi: 10.1007/s10072-012-0996-y. Epub 2012 Mar 6. Erratum in: Neurol Sci. 2014 Feb;35(2):333. Volontè, Antonietta [corrected to Volontè, Maria Antonietta].

PMID:
22391679
2.

Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis.

Ahn BY, Song ES, Cho YJ, Kwon OW, Kim JK, Lee NG.

Proteomics. 2006 Feb;6(4):1200-9.

PMID:
16421937
3.

Detection of autoantibody to aldolase B in sera from patients with troglitazone-induced liver dysfunction.

Maniratanachote R, Shibata A, Kaneko S, Yamamori I, Wakasugi T, Sawazaki T, Katoh K, Tokudome S, Nakajima M, Yokoi T.

Toxicology. 2005 Dec;216(1):15-23. Epub 2005 Aug 22.

PMID:
16115720
4.

Autoantibody to aldolase in acute and chronic hepatitis.

Brown C, Toh BH, Pedersen JS, Clarke FM, Mackay IR, Gust I.

Pathology. 1987 Oct;19(4):347-50.

PMID:
3328140
5.
6.

Tyrosine nitration impairs mammalian aldolase A activity.

Koeck T, Levison B, Hazen SL, Crabb JW, Stuehr DJ, Aulak KS.

Mol Cell Proteomics. 2004 Jun;3(6):548-57. Epub 2004 Feb 20.

7.

Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approaches.

Katsumata Y, Kawaguchi Y, Baba S, Hattori S, Tahara K, Ito K, Iwasaki T, Yamaguchi N, Oyama M, Kozuka-Hata H, Hattori H, Nagata K, Yamanaka H, Hara M.

Mol Cell Proteomics. 2011 Jun;10(6):M110.005330. doi: 10.1074/mcp.M110.005330. Epub 2011 Apr 7.

8.

Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis.

Saulot V, Vittecoq O, Charlionet R, Fardellone P, Lange C, Marvin L, Machour N, Le Loët X, Gilbert D, Tron F.

Arthritis Rheum. 2002 May;46(5):1196-201.

9.

Anti-carbonic anhydrase III autoantibodies in vasculitis syndrome.

Saito R, Watanabe H, Asano T, Suzuki E, Iwadate H, Kobayashi H, Ohira H.

Int J Rheum Dis. 2013 Jun;16(3):339-46. doi: 10.1111/1756-185X.12089. Epub 2013 May 23.

PMID:
23981757
10.

Identification of aldolase as a target antigen in Alzheimer's disease.

Mor F, Izak M, Cohen IR.

J Immunol. 2005 Sep 1;175(5):3439-45.

11.

Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes.

Goëb V, Thomas-L'Otellier M, Daveau R, Charlionet R, Fardellone P, Le Loët X, Tron F, Gilbert D, Vittecoq O.

Arthritis Res Ther. 2009;11(2):R38. doi: 10.1186/ar2644. Epub 2009 Mar 10.

12.

Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.

Fujita Y, Nakanishi T, Hiramatsu M, Mabuchi H, Miyamoto Y, Miyamoto A, Shimizu A, Tanigawa N.

Clin Cancer Res. 2006 Nov 1;12(21):6415-20.

13.

Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach.

Matsuo K, Xiang Y, Nakamura H, Masuko K, Yudoh K, Noyori K, Nishioka K, Saito T, Kato T.

Arthritis Res Ther. 2006;8(6):R175.

14.

Identification of proteomic signatures associated with lung cancer and COPD.

Pastor MD, Nogal A, Molina-Pinelo S, Meléndez R, Salinas A, González De la Peña M, Martín-Juan J, Corral J, García-Carbonero R, Carnero A, Paz-Ares L.

J Proteomics. 2013 Aug 26;89:227-37. doi: 10.1016/j.jprot.2013.04.037. Epub 2013 May 9.

PMID:
23665002
15.

Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry.

Tilleman K, Van Beneden K, Dhondt A, Hoffman I, De Keyser F, Veys E, Elewaut D, Deforce D.

Proteomics. 2005 May;5(8):2247-57.

PMID:
15846842
18.

Identification of four isoforms of aldolase B down-regulated in hepatocellular carcinoma tissues by means of two-dimensional Western blotting.

Wang Y, Kuramitsu Y, Takashima M, Yokoyama Y, Iizuka N, Tamesa T, Sakaida I, Oka M, Nakamura K.

In Vivo. 2011 Nov-Dec;25(6):881-6.

PMID:
22021680
19.

Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.

Lu Y, Jia L, He S, Hurley MC, Leys MJ, Jayasundera T, Heckenlively JR.

Arch Ophthalmol. 2009 Dec;127(12):1572-80. doi: 10.1001/archophthalmol.2009.311.

20.

Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.

Tsunemi S, Nakanishi T, Fujita Y, Bouras G, Miyamoto Y, Miyamoto A, Nomura E, Takubo T, Tanigawa N.

Oncol Rep. 2010 Apr;23(4):949-56.

PMID:
20204278

Supplemental Content

Support Center